85 related articles for article (PubMed ID: 1692572)
1. Differential inhibition of HIV-1 cell binding and HIV-1-induced syncytium formation by low molecular weight sulphated polysaccharides.
Montefiori DC; Robinson WE; Modliszewski A; Rowland JM; Schuffman SS; Mitchell WM
J Antimicrob Chemother; 1990 Mar; 25(3):313-8. PubMed ID: 1692572
[TBL] [Abstract][Full Text] [Related]
2. Sulfated polysaccharides as potent inhibitors of HIV-induced syncytium formation: a new strategy towards AIDS chemotherapy.
Baba M; Schols D; Pauwels R; Nakashima H; De Clercq E
J Acquir Immune Defic Syndr (1988); 1990; 3(5):493-9. PubMed ID: 1691288
[TBL] [Abstract][Full Text] [Related]
3. Mechanism of anti-human immunodeficiency virus action of polyoxometalates, a class of broad-spectrum antiviral agents.
Yamamoto N; Schols D; De Clercq E; Debyser Z; Pauwels R; Balzarini J; Nakashima H; Baba M; Hosoya M; Snoeck R
Mol Pharmacol; 1992 Dec; 42(6):1109-17. PubMed ID: 1282664
[TBL] [Abstract][Full Text] [Related]
4. Dextran sulfate and other polyanionic anti-HIV compounds specifically interact with the viral gp120 glycoprotein expressed by T-cells persistently infected with HIV-1.
Schols D; Pauwels R; Desmyter J; De Clercq E
Virology; 1990 Apr; 175(2):556-61. PubMed ID: 1691563
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of human immunodeficiency virus type-1-induced syncytium formation and cytopathicity by complestatin.
Momota K; Kaneko I; Kimura S; Mitamura K; Shimada K
Biochem Biophys Res Commun; 1991 Aug; 179(1):243-50. PubMed ID: 1715691
[TBL] [Abstract][Full Text] [Related]
6. Flow cytometric method to monitor the destruction of CD4+ cells following their fusion with HIV-infected cells.
Schols D; Pauwels R; Desmyter J; De Clercq E
Cytometry; 1990; 11(6):736-43. PubMed ID: 1696539
[TBL] [Abstract][Full Text] [Related]
7. Maleylated human serum albumin inhibits HIV-1 infection in vitro.
Takami M; Sone T; Mizumoto K; Kino K; Tsunoo H
Biochim Biophys Acta; 1992 Dec; 1180(2):180-6. PubMed ID: 1281431
[TBL] [Abstract][Full Text] [Related]
8. A monoclonal antibody to the gp120-CD4 complex has differential effect on HIV-induced syncytium formation and viral infectivity.
Konopka K; Pretzer E; Celada F; Düzgüneş N
J Gen Virol; 1995 Mar; 76 ( Pt 3)():669-79. PubMed ID: 7897355
[TBL] [Abstract][Full Text] [Related]
9. HIV-induced syncytium formation requires the formation of conjugates between virus-infected and uninfected T-cells in vitro.
Busso M; Thornthwaite J; Resnick L
AIDS; 1991 Dec; 5(12):1425-32. PubMed ID: 1687645
[TBL] [Abstract][Full Text] [Related]
10. Differential effects of a hydrophobic tripeptide on human immunodeficiency virus type 1 (HIV-1)-induced syncytium formation and viral infectivity.
Konopka K; Pretzer E; Düzgünes N
Biochem Biophys Res Commun; 1995 Mar; 208(1):75-81. PubMed ID: 7887968
[TBL] [Abstract][Full Text] [Related]
11. Anti-HIV-1 activity and structure-activity-relationship study of a fucosylated glycosaminoglycan from an echinoderm by targeting the conserved CD4 induced epitope.
Lian W; Wu M; Huang N; Gao N; Xiao C; Li Z; Zhang Z; Zheng Y; Peng W; Zhao J
Biochim Biophys Acta; 2013 Oct; 1830(10):4681-91. PubMed ID: 23769857
[TBL] [Abstract][Full Text] [Related]
12. Anti-HIV activity of dextran sulphate as determined under different experimental conditions.
Nakashima H; Yoshida O; Baba M; De Clercq E; Yamamoto N
Antiviral Res; 1989; 11(5-6):233-46. PubMed ID: 2478075
[TBL] [Abstract][Full Text] [Related]
13. Mode of action of 5'-linked cholesteryl phosphorothioate oligodeoxynucleotides in inhibiting syncytia formation and infection by HIV-1 and HIV-2 in vitro.
Stein CA; Pal R; DeVico AL; Hoke G; Mumbauer S; Kinstler O; Sarngadharan MG; Letsinger RL
Biochemistry; 1991 Mar; 30(9):2439-44. PubMed ID: 1705817
[TBL] [Abstract][Full Text] [Related]
14. Preparation and anti-HIV activities of aurintricarboxylic acid fractions and analogues: direct correlation of antiviral potency with molecular weight.
Cushman M; Wang PL; Chang SH; Wild C; De Clercq E; Schols D; Goldman ME; Bowen JA
J Med Chem; 1991 Jan; 34(1):329-37. PubMed ID: 1704065
[TBL] [Abstract][Full Text] [Related]
15. [The antiviral action of recombinant forms of the human T-lymphocyte CD4 receptor].
Zverev VV; Maliushova VV; Sidorov AV; Pugach AV; Shukhmina NR; Pille ER; Mel'nikova NL; Andzhaparidze OG
Vopr Virusol; 1994; 39(2):56-9. PubMed ID: 7517083
[TBL] [Abstract][Full Text] [Related]
16. A natural sulfated polysaccharide, calcium spirulan, isolated from Spirulina platensis: in vitro and ex vivo evaluation of anti-herpes simplex virus and anti-human immunodeficiency virus activities.
Hayashi K; Hayashi T; Kojima I
AIDS Res Hum Retroviruses; 1996 Oct; 12(15):1463-71. PubMed ID: 8893054
[TBL] [Abstract][Full Text] [Related]
17. Syncytium forming capacity of HIV 1 strains in inhibited by pretreatment of CD4 expressing cells with 3'-azido-3'-deoxythymidine but not by alpha interferon.
Ruţă SM; Cernescu C
Rev Roum Virol; 1994; 45(3-4):171-83. PubMed ID: 7619738
[TBL] [Abstract][Full Text] [Related]
18. Mycophenolic acid inhibits syncytium formation accompanied by reduction of gp120 expression.
Ui H; Asanuma S; Chiba H; Takahashi A; Yamaguchi Y; Masuma R; Omura S; Tanaka H
J Antibiot (Tokyo); 2005 Aug; 58(8):514-8. PubMed ID: 16266123
[TBL] [Abstract][Full Text] [Related]
19. Novel sulfated polysaccharides: dissociation of anti-human immunodeficiency virus activity from antithrombin activity.
Baba M; De Clercq E; Schols D; Pauwels R; Snoeck R; Van Boeckel C; Van Dedem G; Kraaijeveld N; Hobbelen P; Ottenheijm H
J Infect Dis; 1990 Feb; 161(2):208-13. PubMed ID: 2405068
[TBL] [Abstract][Full Text] [Related]
20. Dextran sulfate suppression of viruses in the HIV family: inhibition of virion binding to CD4+ cells.
Mitsuya H; Looney DJ; Kuno S; Ueno R; Wong-Staal F; Broder S
Science; 1988 Apr; 240(4852):646-9. PubMed ID: 2452480
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]